Xiao-Luan Yan
Overview
Explore the profile of Xiao-Luan Yan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
131
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Su Y, Jin K, Wang H, Wang Y, Yan X, Wang K, et al.
Eur J Surg Oncol
. 2024 Oct;
:108777.
PMID: 39477732
Introduction: Neoadjuvant chemotherapy is becoming routine for colorectal liver metastasis (CRLM) in patients with high risks of recurrence or in whom resection is difficult. This retrospective study aimed to establish...
2.
Su Y, Liu W, Yan X, Wang L, Liu M, Wang H, et al.
Cancer Med
. 2023 Feb;
12(8):9559-9569.
PMID: 36846977
Background: Patients with a 5-year recurrence-free survival post liver resection for colorectal cancer liver metastases (CRLM) are considered to be potentially cured. However, there is a deficit of data on...
3.
Bai L, Yan X, Lu Y, Meng Q, Rong Y, Ye L, et al.
Ann Surg Oncol
. 2022 Mar;
PMID: 35254582
Background: Colorectal cancer liver metastasis (CRLM) is a determining factor affecting the survival of colorectal cancer (CRC) patients. This study aims at developing a novel prognostic stratification tool for CRLM...
4.
Xu D, Zhu H, Wang Y, Jin K, Yan X, Li J, et al.
Int J Colorectal Dis
. 2022 Feb;
37(4):805-814.
PMID: 35188594
Background: The prognosis of patients with liver metastases during or early after adjuvant chemotherapy for colorectal cancer (CRC) is significantly worse. This study aimed to explore the efficacy of perioperative...
5.
Yan X, Wang K, Bao Q, Wang H, Jin K, Su Y, et al.
J Surg Oncol
. 2022 Feb;
125(6):1002-1012.
PMID: 35171534
Objective: To assess prognostic influences of RAS mutational status and primary tumor site on cases with colorectal liver metastasis (CRLM) who underwent hepatectomy. Methods: Clinicopathological data of 762 patients with...
6.
Xu D, Wang Y, Yan X, Li J, Wang K, Xing B
J Gastrointest Oncol
. 2021 Sep;
12(4):1498-1508.
PMID: 34532105
Background: Preoperative chemotherapy has widely been used in colorectal cancer liver metastasis (CRLM). Pathological response to chemotherapy is very important in evaluating tumor biology. However, there is still a lack...
7.
Wang H, Yan X, Wang L, Zhang M, Yang C, Wei-Liu , et al.
J Transl Med
. 2021 Jul;
19(1):313.
PMID: 34281583
Background: The exploration of genomic alterations in Chinese colorectal liver metastasis (CRLM) is limited, and corresponding genetic biomarkers for patient's perioperative management are still lacking. This study aims to understand...
8.
Yan X, Wang K, Bao Q, Wang H, Jin K, Wang J, et al.
BMC Surg
. 2021 Jun;
21(1):302.
PMID: 34187443
Background: En bloc right hemicolectomy with pancreatoduodenectomy (RHCPD) is the optimum treatment to achieve the adequate margin of resection (R0) for locally advanced right-sided colon cancer with duodenal invasion. Information...
9.
Wang K, Liu M, Wang H, Jin K, Yan X, Bao Q, et al.
Front Oncol
. 2021 Apr;
11:643375.
PMID: 33869034
Deficiency of the DNA damage repair (DDR) signaling pathways is potentially responsible for genetic instability and oncogenesis in tumors, including colorectal cancer. However, the correlations of mutated DDR signaling pathways...
10.
Xu D, Yan X, Liu J, Li J, Xing B
J Cancer
. 2020 Oct;
11(21):6256-6263.
PMID: 33033509
Preoperative chemotherapy is widely used for colorectal liver metastasis (CRLM). Pathological complete response (PCR) after chemotherapy indicates complete tumor regression and an extremely favorable prognosis. This study aimed to explore...